MITat1 |
Preferred name1 |
Lab of origin2 |
Local Names3 |
Copies4 |
BES5 |
GenBank Number |
Comments6 |
1.1 |
Lister
427-1 |
Cross |
060 |
? |
|
Genbank
sequence by Carrington Lab |
|
1.2 |
Lister
427-2 |
Cross |
221 |
1 |
1 |
Genbank
sequence by Carrington Lab |
|
1.3 |
Lister
427-3 |
Cross |
224
(Luisa 17.9) |
2 |
6
& 7 |
Genbank
sequence by Cross Lab |
|
1.4 |
Lister
427-4 |
Cross |
117 |
>5 |
|
Genbank
sequence by Cross Lab |
|
1.5 |
Lister
427-5 |
Cross |
118 |
2 |
|
Genbank
sequence by Carrington Lab |
|
1.6 |
Lister
427-6 |
Cross |
121 |
4–5 |
3 |
Genbank
sequence by Carrington Lab |
|
1.7 |
Lister
427-7 |
Cross |
055 |
? |
|
Genbank
sequence by Carrington Lab |
|
1.8 |
Lister
427-8 |
Borst/Cross
|
1.8
(Dreesen OD1) |
? |
12
& 14?? |
Genbank
sequence by Cross Lab |
|
1.9 |
Lister
427-9 |
Borst/Cross |
Luisa
17. 23 (Borst VO2) |
2 |
2 |
Genbank
sequence by Cross Lab |
|
1.10 |
Lister
427-10 |
Cross |
VSG
K (Navarro) |
? |
|
no
sequence |
|
1.11 |
Lister
427-11 |
Cross |
bR2
(Davies) |
2–3 |
15 |
Genbank
sequence by Cross Lab |
|
1.12 |
Lister
427-12 |
Cross |
Oliver
501c2 (Navarro B) |
? |
|
Genbank
sequence by Cross Lab |
|
1.13 |
Lister
427-13 |
Cross |
Luisa
17.13 |
2 |
17 |
Genbank
sequence by Cross Lab |
|
1.14 |
Lister
427-14 |
Rudenko |
TAR64 |
|
8 |
Sanger
sequencing |
|
1.15 |
Lister
427-15 |
Rudenko |
TAR134 |
|
10 |
Sanger
sequencing |
|
1.16 |
Lister
427-16 |
Rudenko |
TAR122 |
|
11 |
Sanger
sequencing |
|
1.17 |
Lister
427-17 |
Cross |
Luisa
17.7 (Rudenko JS1) |
1 |
13 |
Genbank
sequence by Cross Lab |
|
1.18 |
Lister
427-18 |
Cross/Hajduk |
Luisa
17.22 (Hajduk 800) |
? |
5 |
Genbank
sequence by Cross Lab (top) Hajduk sequence (bottom) |
|
1.19 |
Lister
427-19 |
Rudenko |
TAR10 |
|
14 |
Sanger
sequencing |
|
1.20 |
Lister
427-20 |
|
|
|
|
|
To
be assigned |
1.21 |
Lister
427-21 |
Cross |
Luisa
17.21 (Horn T3) |
2/3 |
4 |
Genbank
sequence by Cross Lab |
1.22 |
Borst/Clayton |
222 |
? |
|
Genbank
sequence by Clayton Lab |
||
1.23 |
Lister
427-23 |
Papavasiliou |
28 |
1 |
MC |
Papavasiliou
Lab |
|
1.24 |
Lister
427-24 |
Papavasiliou |
31 |
1 |
MC |
Papavasiliou
Lab |
|
1.25 |
Lister
427-25 |
Papavasiliou |
42 |
1 |
MC |
Papavasiliou
Lab |
|
1.26 |
Lister
427-26 |
|
|
|
|
|
To
be assigned |
1.27 |
Lister
427-27 |
|
|
|
|
|
To
be assigned |
1.28 |
Lister
427-28 |
|
|
|
|
|
To
be assigned |
1.29 |
Lister
427-29 |
|
|
|
|
|
To
be assigned |
1.30 |
Lister
427-30 |
Gull |
S8 |
1 |
MC |
Genbank
sequence by Gull Lab. Absent from our cells. |
|
1.31 |
Lister
427-31 |
Gull |
G4 |
? |
MC |
Genbank
sequence by Gull Lab. Multi-copy (most on MCs) |
|
|
|
Rudenko
|
NA1 |
? |
|
|
identified
in 2005 Mol Micro paper |
|
|
|
|
|
|
|
|
New entries from our
lab, unless otherwise annotated, were amplified by RT-PCR using primers
corresponding to the 5« spliced leader
and the VSG 3« UTR conserved 14-mer (for protocol see our web site), both of
which are excluded from the
sequence shown, which starts at the first nt following the spliced leader and ends before the
first nt of the conserved 3« UTR sequence.
MITat 1.3: Originally identified as clone 224, isolated in 1978 by E.N. Miller and M.J. Turner (unpublished) as a relapse from clone 221 (MITat 1.2). VSG purified and characterized by G.A.M. Cross (1979, unpublished).
MITat 1.8: Short 3' end sequence previously reported (Accession X00625). Michels, P.A.M., van der Ploeg, L.H.T., Liu, A.Y.C. and Borst, P. (1984) The inactivation and reactivation of an expression-linked gene copy for a variant surface glycoprotein in Trypanosoma brucei. EMBO J., 3, 1345-1351.
MITat 1.9: VSG MITat 1.9 sequence previously unpublished and referred to as VSG VO2, but its expression and chromosomal location have been described in several papers, the most relevant of which are the two following.~~Rudenko, G., Chaves, I., Dirks-Mulder, A. and Borst, P. (1998) Selection for activation of a new variant surface glycoprotein gene expression site in Trypanosoma brucei can result in deletion of the old one. Mol. Biochem. Parasitol., 95, 97-109.~~Berriman, M., Hall, N., Sheader, K., Bringaud, F., Tiwari, B., Isobe, T., Bowman, S., Corton, C., Clark, L., Cross, G.A.M., Hoek, M., Zanders, T., Berberof, M., Borst, P. and Rudenko, G. (2002) The architecture of variant surface glycoprotein gene expression sites in Trypanosoma brucei. Mol. Biochem. Parasitol., 122, 131-140.
MITat 1.11: Originally identified as VSG bR2 (Liu, A.Y., Michels, P.A., Bernards, A. and Borst, P. (1985) Trypanosome variant surface glycoprotein genes expressed early in infection. J. Mol. Biol., 175, 383-386).~~Further characterized by Davies, K.P., Carruthers, V.B. and Cross, G.A.M. (1997) Manipulation of the VSG co-transposed region increases expression-site switching in Trypanosoma brucei. Mol. Biochem. Parasitol., 86, 163-177.~~Horn, D. and Cross, G.A.M. (1997) Analysis of Trypanosoma brucei vsg expression site switching in vitro. Mol. Biochem. Parasitol., 84, 189-201.~~Partly sequenced previously (Davies, K. and Cross, G.A.M. unpublished).
MITat 1.12: Corresponds to vsgB (Navarro and Cross, unpublished partial sequence) in Navarro, M. and Cross, G.A.M. (1996) DNA rearrangements associated with multiple consecutive directed antigenic switches in Trypanosoma brucei. Mol. Cell. Biol., 16, 3615-3625.
MITat 1.21: Previous partial sequence D. Horn and G.A.M. Cross, unpublished.
1 Although only the original 8 MITat numbers strictly fit the definition for this ÔatÕ-based nomenclature, in being characterized at the Molteno Institute, ÔghostÕ MITat numbers have been assigned to all Lister 427 VSGs. I would much prefer to adopt a strain-designated number. The ancient ÔatÕ system was never satisfactory and is currently totally inappropriate and inadequate as it tags the variant types to particular labs, and it is based on polyvalent phenotyping reagents (antibodies) that do not necessarily resolve genotypes. It is not linked to the genotype! An alternative system would refer to the expressed genotype: Lister 427-13.2, for example, for the variant 13 family gene 2. The gene number only has to be used if it is really necessary to distinguish a particular member of the family and the number can be omitted from the prototype.
2 The lab in which this variant was first characterized plus, if different, the lab from which the complete gene sequence was determined.
3 LabÕs ÔpetÕ name, usually corresponding to or based upon a clone number.
4 The number of copies is likely to vary depending on propagation history among different labs.
5 ES numbers in red indicate Intermediate Chromosome
6 Unless a TAR clone is mentioned, the GenBank sequences are for cDNA. TAR clones are cloned expression sites sequenced by the Sanger Institute.